Literature DB >> 23526308

Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin.

P Lutz1, M Parcina, I Bekeredjian-Ding, A Hoerauf, C P Strassburg, U Spengler.   

Abstract

Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis. Recently, rifaximin, a non-absorbable antibiotic which is used to prevent recurrent hepatic encephalopathy, has been proposed as effective prophylaxis for SBP. Here, we present an unusual case of SBP under treatment with rifaximin. A 50-year-old woman with liver cirrhosis was admitted because of tense ascites and abdominal pain. She was under long-term oral prophylaxis with rifaximin due to hepatic encephalopathy. Paracentesis revealed SBP caused by Pasteurella multocida, which was sensitive to multiple antibiotics, including rifaximin. Treatment with ceftriaxone resulted in rapid resolution of the peritonitis and restoration of the patient. Since P. multocida is usually transmitted from pets, the patient's cat was tested and could be identified as the most likely source of infection. This case should elicit our awareness that uncommon pathogens and unusual routes of transmission may lead to SBP, despite antibacterial prophylaxis with non-absorbable antibiotics. Nevertheless, such infections may still remain sensitive to systemic therapy with conventional antibiotics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23526308     DOI: 10.1007/s15010-013-0449-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  Rifaximin intake leads to emergence of rifampin-resistant staphylococci.

Authors:  Thomas Valentin; Eva Leitner; Angelika Rohn; Ines Zollner-Schwetz; Martin Hoenigl; Helmut J F Salzer; Robert Krause
Journal:  J Infect       Date:  2010-11-10       Impact factor: 6.072

3.  The role of rifaximin in the primary prophylaxis of spontaneous bacterial peritonitis in patients with liver cirrhosis.

Authors:  Mohamad A Hanouneh; Ibrahim A Hanouneh; Jana G Hashash; Ryan Law; Jamak Modaresi Esfeh; Rocio Lopez; Nyla Hazratjee; Thomas Smith; Nizar N Zein
Journal:  J Clin Gastroenterol       Date:  2012-09       Impact factor: 3.062

4.  Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study.

Authors:  Javier Fernández; Juan Acevedo; Miriam Castro; Orlando Garcia; Carlos Rodríguez de Lope; Daria Roca; Marco Pavesi; Elsa Sola; Leticia Moreira; Anibal Silva; Tiago Seva-Pereira; Francesco Corradi; Jose Mensa; Pere Ginès; Vicente Arroyo
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

Review 5.  Spontaneous bacterial peritonitis with Pasteurella multocida in cirrhosis: case report and review of literature.

Authors:  Ila Tamaskar; Keyvan Ravakhah
Journal:  South Med J       Date:  2004-11       Impact factor: 0.954

6.  Rifaximin in the treatment of recurrent Clostridium difficile infection.

Authors:  E Mattila; P Arkkila; P S Mattila; E Tarkka; P Tissari; V-J Anttila
Journal:  Aliment Pharmacol Ther       Date:  2012-10-24       Impact factor: 8.171

Review 7.  Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic.

Authors:  Carmelo Scarpignato; Iva Pelosini
Journal:  Digestion       Date:  2006-02-08       Impact factor: 3.216

Review 8.  Pasteurella multocida infections. II. Pasteurella multocida infection in man unrelated to animal bite.

Authors:  W T Hubbert; M N Rosen
Journal:  Am J Public Health Nations Health       Date:  1970-06

9.  Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori.

Authors:  Sang-Pil Yun; Han Gyung Seon; Chang Soo Ok; Kwang Ho Yoo; Min Kyung Kang; Won Hee Kim; Chang Il Kwon; Kwang Hyun Ko; Seong Gyu Hwang; Pil Won Park; Sung Pyo Hong
Journal:  Gut Liver       Date:  2012-10-18       Impact factor: 4.519

Review 10.  Cat induced Pasteurella multocida peritonitis in peritoneal dialysis: a case report and review of the literature.

Authors:  Patricia M Sol; Nicole C A J van de Kar; Michiel F Schreuder
Journal:  Int J Hyg Environ Health       Date:  2012-05-07       Impact factor: 5.840

View more
  4 in total

Review 1.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Authors:  Philipp Lutz; Hans Dieter Nischalke; Christian P Strassburg; Ulrich Spengler
Journal:  World J Hepatol       Date:  2015-03-27

2.  Disseminated Pasteurella multocida in a patient with liver cirrhosis and spontaneous bacterial peritonitis - The role of cirrhosis-associated immune dysfunction.

Authors:  Libardo Rueda Prada; Milena Cardozo; Ann Hudson; Matthias McDermott; Diana C Urbina Verjel; Igor Dumic
Journal:  IDCases       Date:  2022-06-21

3.  [Characterization of bacterial flora in community peritonitis carried out in Burkina Faso].

Authors:  Mahamoudou Sanou; Armand Ky; Edgard Ouangre; Cyrille Bisseye; Adama Sanou; Bolni Marius Nagalo; Drissa Sanou; Jacques Simporé; Lassana Sangare; Rasmata Traore
Journal:  Pan Afr Med J       Date:  2014-05-05

4.  Pasteurella multocida Bacteremia and Peritonitis in a Patient With Cirrhosis: A Life-Threatening Case From a Prick of a Cactus.

Authors:  Jodi-Anne Wallace; Jonathan Hussain; Alberto Unzueta; Giuseppe Morelli
Journal:  J Investig Med High Impact Case Rep       Date:  2017-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.